Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

147

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N01AX10	DORMIFOR	G	Propofol - 1%	1%	Injectable emulsion	1,081,473 L.L
N01AX10	PROPOFOL 1% MCT/LCT FRESENIUS	G	Propofol - 1%	1%	Injectable emulsion	847,965 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	? 1% LIDOCAINE HCL USP	G	Lidocaine HCl - 1%	1%	Injectable solution	76,791 L.L
N01BB02	CHLORHYDRATE DE LIDOCAINE RENAUDIN	G	Lidocaine (HCl) - 10mg/ml	1%	Injectable solution	591,291 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
V03AB14	PROSULF 1%	B	Protamine sulfate - 50mg/5ml	1%	Injectable solution	8,216,459 L.L
D11AH02	ELIDEL	B	Pimecrolimus - 10mg/g	1%	Cream	1,780,591 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Shampoo	195,817 L.L
R06AB02	HISTAMED	G	Dexchlorpheniramine maleate - 1%	1%	Gel	477,384 L.L
P03AB02	GAMMAPHARM	G	Lindane - 1%	1%	Shampoo	195,817 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Lotion	167,660 L.L
P03AC04	PERMACARE	G	Permethrin - 1%	1%	Lotion	590,011 L.L
D01AC03	ECONAZ	G	Econazole nitrate - 1%	1%	Cream	307,164 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 1%	1%	Drops	170,668 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	350,743 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
D01AE15	TERMINUS	G	Terbinafine HCl - 1%	1%	Cream	747,176 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	962,191 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	506,629 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Solution	355,798 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10mg/g	1%	Cream	345,368 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10ml/ml	1%	Solution	159,917 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	191,126,390 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	L.L
H01AB01	THYROGEN	BioHuman	Thyrotropin alfa - 0.9mg	0.9mg	Injectable lyophilised powder for solution+diluent	65,558,997 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L

...

147

...